Literature DB >> 15308439

Refractory neurosarcoidosis: a dramatic response to infliximab.

John D Carter, Joanne Valeriano, Frank B Vasey, Bryan Bognar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15308439     DOI： 10.1016/j.amjmed.2004.03.013

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  13 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Authors:  Fleur Cohen Aubart; Diane Bouvry; Damien Galanaud; Caroline Dehais; Guillaume Mathey; Dimitri Psimaras; Julien Haroche; Corinne Pottier; Miguel Hie; Alexis Mathian; Hervé Devilliers; Hilario Nunes; Dominique Valeyre; Zahir Amoura
Journal:  J Neurol       Date:  2017-03-04       Impact factor: 4.849

Review 3.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

Authors:  Michael Moravan; Benjamin M Segal
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

5.  Dramatic response to infliximab in refractory neurosarcoidosis.

Authors:  Sreekanth Chintamaneni; Aarat M Patel; Samuel B Pegram; Hirenkumar Patel; Heidi Roppelt
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

6.  Cardiac sarcoidosis responding to monotherapy with infliximab.

Authors:  Imad Uthman; Zahi Touma; Maurice Khoury
Journal:  Clin Rheumatol       Date:  2007-03-30       Impact factor: 2.980

7.  Neurosarcoidosis presenting as a cerebellar mass.

Authors:  Gautam Kumar; Caroline A Kang; Caterina Giannini
Journal:  J Gen Intern Med       Date:  2007-07-06       Impact factor: 5.128

8.  Neurosarcoidosis.

Authors:  Ashok V Patel; David E Stickler; William R Tyor
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

9.  Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations.

Authors:  J Chad Hoyle; Courtney Jablonski; Herbert B Newton
Journal:  Neurohospitalist       Date:  2014-04

10.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.